You're signed outSign in or to get full access.
About
Naomi Pacalin, PhD, is an Analyst at Sofinnova Investments, where she focuses on investments in biopharmaceutical companies across diverse disease areas and therapeutic modalities. Her role involves evaluating opportunities in biotechnology and life sciences, leveraging deep technical expertise to support the firm’s venture and private equity strategies specifically within the health and biopharma sectors.
Prior to joining Sofinnova as an Analyst in 2024, Naomi completed her PhD in Bioengineering at Stanford University, specializing in epigenomics and gene regulation in health and disease, with hands-on research in CRISPR epigenetic editing and single-cell sequencing. She also served as a Venture Fellow at Sofinnova and contributed to leadership roles in student biotech organizations and as a life sciences consultant during her doctoral studies.
Naomi holds a PhD in Bioengineering from Stanford University, with additional degrees in Biological Chemistry and Chemistry from the University of Chicago. Her background combines cutting-edge scientific research with practical experience in investment analysis, making her a valuable asset in identifying and supporting innovative biotech startups and therapeutics opportunities.
Career History
| Organization | Role | Date Range | Details |
|---|---|---|---|
| Sofinnova Investments | Analyst | Jan 2024 to Present | — |
| Stanford University | Bioengineering PhD Student | Sep 2017 to Dec 2023 | Developed next-generation epigenomics approaches leveraging CRISPR, single-cell, and computational methods to defeat cancer & autoimmune disease by better understanding gene regulation. Fellowships: N... |
| Sofinnova Investments | Venture Fellow | Jul 2022 to May 2023 | — |
| Stanford Biotechnology Group | Leadership Team Member | Jun 2018 to Mar 2023 | Student organization supporting Stanford PhD and MBA students interested in careers in the biotech industry, including research, business development, entrepreneurship, investing, and consulting. Prog... |
| Stanford Biotechnology Group | Co-President | Jun 2020 to Jun 2021 | — |
| Mythos Biotechnology Fund | Partner and Analyst | Jan 2019 to Jan 2021 | Biotech investment fund managed by PhD, MBA, and postdoc trainees at Stanford. Focused on small to mid cap public biotech companies. |
| Mythos Biotechnology Fund | Managing Partner | Jan 2019 to Dec 2019 | Performed roles of Executor, including fund accounting and share transactions. |
| Biotech Connection - Bay Area, Inc. | Consultant | Jul 2020 to Sep 2020 | Conducted market opportunity assessment for a biotech company focused on a next-generation sequencing product. |
| The University of Chicago | Research Specialist | Jul 2016 to Jul 2017 | Member of Dr. Jun Huang's Group in the School of Molecular Engineering. Studied T cells using single-cell methods to understand 1) antigen cross-reactivity of T-cell receptors using live-cell imaging ... |
| The University of Chicago | Undergraduate Researcher | Aug 2014 to Jul 2016 | Member of Dr. Matthew Tirrell's Group in the School of Molecular Engineering. Studied the characteristics of the solid to liquid phase transition of polyelectrolyte complexes using peptide polymers. D... |
Education
Stanford University
2017 — 2023
Stanford University Graduate School of Business
2020 — 2020
University of Chicago
2012 — 2016
Skills & Expertise
Others at Sofinnova Investments, Inc. (12)
| Name | Role | Location |
|---|---|---|
 | Analyst | New York, NY , United States |
 | Partner | New York, NY , United States |
 | General Partner | CA , United States |
J John Barrett | Analyst | Boston, MA , United States |
S Sarah Bhagat | General Partner | Menlo Park, CA , United States |
A Ace Isidro | Associate | Boston, MA , United States |
 | Analyst | Boston, MA , United States |
 | Managing Partner | United States |
 | Fund Manager | Ashburn, VA , United States |
M Mike Van | Associate | Stanford, CA , United States |
Similar Fund Managers
| Name | Role | Fund | Location |
|---|---|---|---|
 | Partner | Decheng Capital LLC | San Francisco, CA , United States |
 | Partner | Decheng Capital LLC | New York, NY , United States |
 | Principal | Crosslink Capital Inc. | CA , United States |
D Dane Lewis | Analyst | Crosslink Capital Inc. | San Francisco, CA , United States |
